株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の静脈瘤治療装置市場

Varicose Vein Treatment Devices | US | 2015 | Market Analysis

発行 Millennium Research Group - DRG 商品コード 202059
出版日 ページ情報 英文 109 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
米国の静脈瘤治療装置市場 Varicose Vein Treatment Devices | US | 2015 | Market Analysis
出版日: 2015年08月26日 ページ情報: 英文 109 Pages
概要

米国における静脈瘤治療装置市場は今後、新たな血管内焼灼技術の登場などにより、緩やかに成長する見込です。

当レポートでは、米国における静脈瘤治療装置全体および各装置の市場概要、競合状況、市場シェアおよび今後10年間の市場予測などを提供しています。

第1章 静脈瘤治療装置市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 市場概要
  • 競合概要
  • 競合情勢
  • 市場シェア
  • 市場因子と発展動向

第2章 血管内焼灼装置市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 市場概要
  • 競合概要
  • 競合情勢
  • 市場シェア

第3章 外科的ストリッピング装置市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 市場概要
  • 競合概要
  • 市場シェア

第4章 静脈切除装置市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 市場概要
  • 競合概要
  • 市場シェア

第5章 硬化剤市場

  • 市場概要
  • 市場定義
  • 市場予測データ
    • 一次治療
    • 補助療法
    • クモ状静脈治療
  • 市場動向
  • 競合概要
  • 競合情勢
  • 市場シェア

付録

目次
Product Code: RPUS11VR15

Introduction:

The US varicose vein treatment device market will be characterized by modest growth and the introduction of new endovenous ablation technologies, which will compete with more established modalities over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for varicose vein treatment devices in the US across a 10-year period.

Questions Answered in This Report:

  • New endovenous ablation technologies (such as MOCA and cyanoacrylate adhesive) are being introduced into the US varicose vein market.
    • How quickly are new endovenous ablation modalities being adopted?
    • How will they compete with established treatment options, such as ELA and ERFA?
  • The US is adopting health care reform and looking to reduce costs.
    • What is the current reimbursement situation for endovenous ablation procedures?
    • Are newer endovenous ablation technologies being reimbursed? How is this situation likely to change over the forecast period?
  • Catheter reprocessing is now available to facilities using ERFA devices.
    • How quickly is catheter reprocessing being adopted?
    • What impact will this have on the ERFA disposable device market?
  • The first FDA-approved foam sclerosant, Varithena, has been launched in the US.
    • What barriers to adoption is this new product facing? How successfully will it compete against standard sclerotherapy and endovenous ablation?

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

VERSION HISTORY

1. VARICOSE VEIN TREATMENT DEVICE MARKET

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Competitive Landscape
  • 1.7. Market Shares
  • 1.8. Market Factors and Developments

2. ENDOVENOUS ABLATION DEVICE MARKET

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Competitive Landscape
  • 2.7. Market Shares

3. SURGICAL STRIPPING DEVICE MARKET

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares

4. PHLEBECTOMY DEVICE MARKET

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares

5. SCLEROTHERAPY AGENT MARKET

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
    • 5.3.1. Primary Treatment
    • 5.3.2. Adjunctive Treatment
    • 5.3.3. Spider Vein Treatment
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Competitive Landscape
  • 5.7. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Varicose Vein Treatments, by Procedure Type, US, 2013-2023
  • Figure 2: Varicose Vein Treatment Device Market, by Product Type, US (USD), 2013-2023
  • Table 1: Varicose Vein Treatment Device Market Landscape, US (USD), 2014 and 2023
  • Table 2: Varicose Vein Treatment Device Revenue Market Share Rankings, by Product Type, US, 2014
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Varicose Vein Treatment Device Market, by Product Type, US
  • Table 5: Recent Events in the Varicose Vein Treatment Device Market, US
  • Table 6: Emerging Products for the Varicose Vein Treatment Device Market, US
  • Table 7: Key Report Updates
  • Table 8: Varicose Vein Treatments Covered, US
  • Table 9: Varicose Vein Treatment Devices Covered, US

VERSION HISTORY

  • Table 10: Version History

1. VARICOSE VEIN TREATMENT DEVICE MARKET

  • Figure 3: Varicose Vein Treatments, by Procedure Type, US, 2013-2023
  • Figure 4: Varicose Vein Treatment Device Market, by Product Type, US (USD), 2013-2023
  • Table 11: Varicose Vein Treatments, by Procedure Type, US, 2013-2023
  • Table 12: Varicose Vein Treatments, by Technique, US, 2013-2023
  • Table 13: Primary Varicose Vein Treatments, by Technique, US, 2013-2023
  • Table 14: Adjunctive Varicose Vein Treatments, by Technique, US, 2013-2023
  • Table 15: Varicose Vein Treatment Device Market, by Product Type, US (USD), 2013-2023
  • Figure 5: Varicose Vein Treatment Device Revenue Market Shares, US, 2014
  • Table 16: Varicose Vein Treatment Device Revenue Market Shares, by Product Type, US, 2014
  • Table 17: Factors Impacting the Varicose Vein Treatment Device Market, by Product Type, US
  • Table 18: Recent Events in the Varicose Vein Treatment Device Market, US
  • Table 19: Emerging Products for the Varicose Vein Treatment Device Market, US

2. ENDOVENOUS ABLATION DEVICE MARKET

  • Figure 6: Endovenous Ablation Device Market, by Product Type, US (USD), 2013-2023
  • Table 20: Endovenous Ablation Procedures, by Procedure Type, US, 2013-2023
  • Table 21: Endovenous Ablation Procedures, by Product Type, US, 2013-2023
  • Table 22: Endovenous Ablation Device Market, by Product Type, US (USD), 2013-2023
  • Table 23: ELA Procedures, by Procedure Type, US, 2013-2023
  • Table 24: ELA Device Market, by Component, US (USD), 2013-2023
  • Table 25: ELA Device Market Growth, by Component, US, 2014-2023
  • Table 26: ERFA Procedures, by Procedure Type, US, 2013-2023
  • Table 27: ERFA Device Market, by Component, US (USD), 2013-2023
  • Table 28: ERFA Device Market Growth, by Component, US, 2014-2023
  • Table 29: MOCA Procedures, by Procedure Type, US, 2013-2023
  • Table 30: MOCA Device Market, US, 2013-2023
  • Table 31: Cyanoacrylate Adhesive Procedures, by Procedure Type, US, 2013-2023
  • Table 32: Cyanoacrylate Adhesive Device Market, US, 2013-2023
  • Figure 7: Endovenous Ablation Device Revenue Market Shares, US, 2014
  • Table 33: Endovenous Ablation Device Revenue Market Shares, by Product Type, US, 2014

3. SURGICAL STRIPPING DEVICE MARKET

  • Figure 8: Surgical Stripping Device Market, US (USD), 2013-2023
  • Table 34: Surgical Stripping Device Market, US (USD), 2013-2023
  • Figure 9: Surgical Stripping Device Revenue Market Shares, US, 2014
  • Table 35: Surgical Stripping Device Revenue Market Shares, US, 2014

4. PHLEBECTOMY DEVICE MARKET

  • Figure 10: Powered Phlebectomy Device Market, by Component, US (USD), 2013-2023
  • Table 36: Phlebectomy Procedures, by Procedure Type, US, 2013-2023
  • Table 37: Powered Phlebectomy Device Market, by Component, US (USD), 2013-2023
  • Table 38: Powered Phlebectomy Device Market Growth, by Component, US, 2014-2023
  • Table 39: Powered Phlebectomy Device Revenue Market Shares, US, 2014

5. SCLEROTHERAPY AGENT MARKET

  • Figure 11: Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 40: Sclerotherapy Procedures, by Procedure Type, US, 2013-2023
  • Table 41: Sclerotherapy Procedures, by Agent, US, 2013-2023
  • Table 42: Sclerotherapy Procedures, by Technique, US, 2013-2023
  • Table 43: Sclerotherapy Market, by Procedure Type, US (USD), 2013-2023
  • Table 44: Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 45: Sclerotherapy Market, by Technique, US (USD), 2013-2023
  • Table 46: Primary Treatment Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 47: Primary Treatment Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 48: Primary Treatment Sclerotherapy Market, by Technique, US (USD), 2013-2023
  • Table 49: Primary Treatment Sclerotherapy Market Growth, by Technique, US, 2014-2023
  • Table 50: Primary Treatment Standard Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 51: Primary Treatment Standard Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 52: Primary Treatment MOCA Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 53: Primary Treatment MOCA Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 54: Adjunctive Treatment Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 55: Adjunctive Treatment Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 56: Adjunctive Treatment Sclerotherapy Market, by Technique, US (USD), 2013-2023
  • Table 57: Adjunctive Treatment Sclerotherapy Market Growth, by Technique, US, 2014-2023
  • Table 58: Adjunctive Treatment Standard Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 59: Adjunctive Treatment Standard Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 60: Adjunctive Treatment Standard Sclerotherapy Sotradecol Procedures, by State, US, 2013-2023
  • Table 61: Adjunctive Treatment Standard Sclerotherapy Compounded STS Procedures, by State, US, 2013-2023
  • Table 62: Adjunctive Treatment Standard Sclerotherapy Asclera Procedures, by State, US, 2013-2023
  • Table 63: Adjunctive Treatment Standard Sclerotherapy Compounded Polidocanol Procedures, by State, US, 2013-2023
  • Table 64: Adjunctive Treatment MOCA Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 65: Adjunctive Treatment MOCA Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Table 66: Spider Vein Treatment Sclerotherapy Market, by Agent, US (USD), 2013-2023
  • Table 67: Spider Vein Treatment Sclerotherapy Market Growth, by Agent, US, 2014-2023
  • Figure 12: Sclerotherapy Agent Revenue Market Shares, US, 2014
  • Table 68: Sclerotherapy Agent Revenue Market Shares, US, 2014

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 69: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Back to Top